Key facts
- Notable investors include Dongying Financial Holding Investment Management Company.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Jifeng Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Jifeng Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jifeng Biotechnology
Manufacturer of bio-based materials intended for medical, food, and industrial applications. The company offers plant-derived polymers, modified starches, capsule alternatives, biodegradable packaging, and functional feed additives, with features including biopolymer synthesis, natural product extraction, material testing, environmental compatibility assessment, and scalable production processes, enabling pharmaceutical companies to access sustainable raw materials, improve product safety enhance ecological performance, and support innovation in bio-based applications across multiple sectors.
- Sector
- Healthcare
- HQ
- Dongying, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Jifeng Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jifeng Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jifeng Biotechnology in its N-PORT filings yet. We sweep new filings monthly.